Medicines Co. (MDCO) Misses Q4 EPS by 23c

February 28, 2017 7:08 AM EST

Medicines Co. (NASDAQ: MDCO) reported Q4 EPS of ($1.77), $0.23 worse than the analyst estimate of ($1.54). Revenue for the quarter came in at $25.2 million versus the consensus estimate of $26.91 million.

For earnings history and earnings-related data on Medicines Co. (MDCO) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings